ArticleFrontiers in oncology2020

Akt Inhibition Is Associated With Favorable Immune Profile Changes Within the Tumor Microenvironment of Hormone Receptor Positive, HER2 Negative Breast Cancer.

Douglas K Marks et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.